1st SwAPP Web-Interview / Experts’s view: MDR Postponement

This 1st SwAPP Web-Interview is intended  as a pilot for similar future events.

Collaborating with subject-matter experts, SwAPP aims to inform interested audiences through a series of online presentations and interviews on specific hot-topics in the pharmaceutical and medical device industries and give you the opportunity to address your most burning questions.

1st SwAPP Web-Interview
Thursday 2 July, 2020, 16:00h

Expert’s View:
EU MDR Postponement: Impact on Medtech & Pharma 
with Case Study:  Substance Based Medical Devices

As a collateral effect of Covid-19 pandemic, the date of application of the EU MDR (Medical Device Regulation) has been postponed by one year to 26 May 2021. Does it really give you the time to do more or is it a chance to do better by first clarifying open questions and then take more relevant strategic decisions?

SwAPP would like to support you in your understanding of the consequences of the MDR postponement on your product portfolio as well as on the considerations regarding your resources that should be allocated to prepare you for long term success.

Based on some concerns already raised by our members, this 1st Web-Interview will also focus on the case study of substance-based medical devices.

Language: English

Schedule:

15:45  Call-in
16:00 Welcome by SwAPP;
Ana Brake, SwAPP, Member of the Board of Directors

16.05  Expert’s view and questions

17:00-17:30 Closing depending on open questions

Registration: please see at the bottom of the page

Participation fees

SwAPP Members                           CHF 20,-
Non-Members                                  CHF 60,-
Students (basic studies)              CHF 20,-
Groups (>5), please contact us: swapp@swapp.ch, re: Webinterview_groups

Cancellation Policy

You may cancel 2 business days before the meeting and receive a full refund minus the cancellation fee of CHF 20.-. Cancellations less than 2 business days before the symposium date will not be refunded.

Accreditation

This event is accredited with 1 credit point by SwAPP/ sgpm

Learning Objectives

To familiarize with the impacts of the new MDR on Pharma and Medtech:

-to understand the consequences of the postponement of the new MDR on Therapeutic Products development

-to be aware of the challenges to face when integrating device components in drug development

-to become acquainted with new key regulatory requirements of substance-based medical devices

Target Audience

New comers and experienced professionals dealing with the new MDR. Any individuals from Industry, Contract Research Organisations, Competent authorities, Notified bodies, Ethics Committees or Academia and working in regulatory affairs, clinical affairs, quality, medical affairs, market access, drug formulation, packaging, process development, manufacturing.

Patronage

Registration

  • Please register via “Xing Events”; see https://swapp.ch/events/swapp-events/
  • Registration and payment are required prior to the event.
  • With your registration you can already submit questions.
  • Technical information to call in-will follow in 1st of July 2020

Start registration and payment via the following “Xing Event” process by ticking SwAPP member or SwAPP non-member (Note: you do not have to register for Xing, skip the password question).

More participants thanks to online event management solutions from XING Events.